For individuals not currently on antiviral therapy, the need for therapy was assessed based on Australian (GESA) guidelines [2] which consider the presence of cirrhosis, disease phase, ALT and HBV DNA (Supplementary Fig. 2). This evidence concerns the gene GPT and Cirrhosis.